SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VIDAMED-"FDA Approval Imminent" (VIDA)
VIDA 0.000010000.0%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: noronha who wrote (7)10/19/1996 2:36:00 PM
From: noronha   of 53
 
To: All
From: Noronha

VIDA released their Q3 earnings on October 17 th. The earnings were in line with expectations but the more salient aspects were the forward looking statements. The CEO was very confident about the TUNA product and said there would be immediate revenue generation in the U.S. They also have an extensive network that will enable them to sell the product everywhere. Finally, they said they were pricing it so that every urologist would have one. Think about that-that's huge. Who's their competition? Nobody since this is a revolutionary product that just got approval from the FDA and nobody is nipping at their heals. Check out their press release on Q3 earnings and see what the CEO said. Since nobody responds I will stop posting for a while and when it rises sharply higher from its current price I will say "I told you so." This posting contains forward looking statements and is subject to uncertainty....but IMO you'll wish you listened.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext